MannKind Corp. (MNKD)
-NasdaqGM 6.23 
0.87(16.23%) 23 May 06:00|After Hours
:
6.39 0.16 (2.57%) 23 May 09:55
| Prev Close: | 5.36 |
|---|
| Open: | 5.54 |
|---|
| Bid: | 6.36 x 100 |
|---|
| Ask: | 6.40 x 300 |
|---|
| 1y Target Est: | 6.14 |
|---|
| Beta: | 1.08 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 5.51 - 6.54 |
|---|
| 52wk Range: | 1.65 - 6.54 |
|---|
| Volume: | 23,289,777 |
|---|
| Avg Vol (3m): | 5,970,640 |
|---|
| Market Cap: | 1.75B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.80 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 42,937.43 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.51 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.14 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | 0.06 |
|---|
Business Summary
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.
View More